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H I G H L I G H T S
• Parental smoking exposure was not only associated with adiposity, but also with unfavorable adipokine profiles.• Parental smoking exposure was associated with metabolic syndrome and its components in Chinese children.• Alterations in adipokine levels might mediate the relation between passive smoking and cardiometabolic disorders in children.
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A B S T R A C T
Background and aims: The mechanisms by which passive smoking leads to cardiometabolic risks, and the tissues
involved still require elucidation. We aimed to evaluate the association of parental smoking exposure (PSE) with
the secretion of adipocyte-derived hormones and cardiometabolic risk factors in Chinese children.
Methods: We included 3150 school children aged 6-18 years from the Beijing Child and Adolescent Metabolic
Syndrome (BCAMS) study. Data on PSE and potential confounders were collected. Six adipokines related to
insulin resistance and metabolic syndrome (MetS) were measured.
Results: PSE was reported in nearly two-thirds of the children. After adjusting for covariates, including age, sex,
pubertal stages, lifestyle factors, and family history, PSE was independently associated with increases of 39.2%
in leptin and 3.9% in retinol binding protein-4 and decreases of 11.4% in fibroblast growth factor 21 and 4.6% in
adiponectin levels (p < 0.05 for all), plus risks for central obesity (OR 1.59, 95% CI 1.33–1.90), elevated blood
pressure (1.22, 1.02–1.46) and MetS (1.43, 1.11–1.85). However, the associations of PSE with hypertension and
MetS were abolished when adjusted for adiposity parameters or the above-mentioned adipokine profiles.
Conclusions: PSE was associated with dysregulation of adipokine levels, which might mediate the development
of MetS in early life.
1. Introduction
The alarming increase in the prevalence of obesity, particular
childhood obesity, and the coexistent disorders in the metabolic syn-
drome (MetS), such as hyperglycemia and hypertension, has reached
epidemic proportions [1]. Meanwhile, exposure to secondhand smoke,
now a serious global problem, was reported to be another important
modifiable factor in addition to unhealthy diet, sedentary lifestyle and
insufficient sleep, associated with obesity and cardiometabolic dis-
orders [2–4]. The Global Burden of Disease study recently showed that
55.9% adolescents were exposed to secondhand smoke in 68 low-in-
come and middle-income countries [5]. In China, the biggest tobacco
producing and consuming country of the world, about 182 million
children are exposed to secondhand smoke everyday, according to data
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from the International Tobacco Control Policy Evaluation Project in
China (ITC China Project) [6]. Primarily exposed to parental tobacco
smoking, children are particularly vulnerable to secondhand smoke
exposure, whose detrimental consequences may track into their adult
life [2,7]. Several previous studies showed that parental smoking ex-
posure (PSE) was associated with childhood obesity, and MetS com-
ponents including abnormal lipid profiles, elevated blood pressure and
impaired glucose regulation [8–12], the mechanisms by which passive
smoking leads to these cardiometabolic disorders and the tissues in-
volved, however, remain unclear, and studies on the Chinese popula-
tion are scarce.
Currently, adipose tissue is regarded as a dynamic endocrine organ
releasing a host of molecules that are generally referred to as adipo-
kines [13], which are involved in energy expenditure, inflammatory
response and cardiometabolic homeostasis [14]. One hypothesis is that
the association of secondhand smoke exposure with cardiometabolic
risk may be mediated through adiposity [8,12,15,16], particularly via
the adverse effects on the endocrine function of the adipose tissue [17].
To date, albeit with limited data, observational studies have provided
evidence for an association between exposure to secondhand smoke and
dysregulation of adipokines, as two inflammation-related adipokines,
leptin and adiponectin, are altered with secondhand smoke exposure
[18,19]. However, other adipokines related to cardiometabolic disease,
such as retinol binding protein 4 (RBP4) [13,20], fibroblast growth
factor 21 (FGF21) [21], resistin [13] and osteonectin [22], have not yet
been systematically investigated in this regard. Therefore, leveraging
the large cohort of Beijing Children and Adolescents Metabolic Syn-
drome (BCAMS) study [23], we aimed to evaluate the association be-
tween PSE, adiposity, adipokine profiles including leptin, resistin, adi-
ponectin, FGF21, osteonectin and RBP4, as well as the MetS and its
components in Chinese school children.
2. Materials and methods
2.1. Study population
Subjects were from the BCAMS study (Supplementary Fig. S1),
which is a longitudinal cohort study of cardiovascular risk factors since
childhood. The study protocol has been reported in detail elsewhere
[23] and is registered at www.clinicaltrails.gov (NCT03421444). In
brief, in 2004 a population-based survey was conducted in the Beijing
area with a representative sample of children and adolescents
(n = 19,593, 50% boys). Approximately 4500 were identified as being
at elevated risk for MetS due to the presence of at least one of the
following risk factors: overweight defined by body mass index
(BMI) ≥ 85th percentile; blood pressures > 90th percentile, total
cholesterol (TC) ≥ 5.2 mmol/L, triglyceride (TG) ≥ 1.7 mmol/L or
fasting plasma glucose (FPG) ≥ 5.6 mmol/L based on finger capillary
blood tests. These high MetS risk subjects, together with a reference
sample of 1095 healthy children, were further invited to undergo
medical examinations for verification based on venipuncture blood
samples. After excluding children who actively smoked (i.e. answered
‘‘Yes’’ to the question whether they had smoked one or more cigarettes
during the 6 months before the interview), 3150 subjects had complete
data and were finally included in the current study. Signed informed
consent was obtained from participants and/or their parents/guardians.
The BCAMS study was approved by the Ethics Committee at the Capital
Institute of Pediatrics in Beijing.
2.2. Clinical and anthropometric measurements
Subjects’ height, weight, waist circumference, systolic blood pres-
sure (SBP) and diastolic blood pressure (DBP) were measured according
to our standard protocol [23]. BMI was calculated as weight divided by
height squared, BMI z-score was calculated by age and gender ac-
cording to the standards of the Centers for Disease Control and
Prevention 2000. Body fat mass percentage (FAT%) was assessed by
bioelectrical impedance analysis (BIA, TANITA TBF-300 A). Pubertal
development was assessed by two pediatricians of the same gender as
the child and pubertal status was scored by Tanner Stage from breast
development in girls and testicular volume in boys.
Information on lifestyle, socioeconomic factors (parents' education
and employment status), family history (diabetes, hypertension, dysli-
pidemia) and parents’ weight and height were obtained by ques-
tionnaire [24]. Activity (≥3 times/week) and inactivity (< 3 times/
week) were assessed by their frequency of participating in extra-
curricular physical activities (cycling, hiking, running, swimming, etc.)
for at least 30 min each time. Diet score was used to evaluate dietary
quality [25].
2.3. Laboratory measurements
Blood samples collected after an overnight (≥10 h) fast were ana-
lyzed for concentrations of FPG, TG, TC, high-density lipoprotein cho-
lesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C),
leptin, resistin, adiponectin, FGF21, osteonectin and RBP4. Serum
leptin and adiponectin were measured by an enzyme-linked im-
munosorbent assay (ELISA) which was developed and performed cen-
trally in the National Health Committee Key Laboratory of
Endocrinology in Peking Union Medical College Hospital. The intra-
and inter-assay CVs for leptin were<7.4% and<9.3% [25], and<
5.4% and<8.5% for adiponectin [26], respectively. Resistin and
FGF21 were measured by using the ELISA kit (Phoenix Pharmaceu-
ticals). The intra and inter-assay CVs were<5.2% and<10.1% for
resistin [23], and< 6.0% and<8.6% for FGF21, respectively [27].
RBP4 was measured by ELISA kits (R&D Systems) with intra- and inter-
assay CVs of 6.2% and 8.5% [20]. For measurement of osteonectin, we
have established a sandwich ELISA system with the intra- and inter-
assay CVs of 5.2% and 9.1% [28]. All samples were assayed blind in
duplicate.
2.4. Exposure to parental smoking
The parental smoking status data was self-reported by participants
and/or their parents/guardians as they were asked whether father and/
or mother smoked. The corresponding answers were “Neither”, “Father
only”, “Mother only” and “Both”. Due to the small proportion of sub-
jects with maternal smoking (2.5%), we classified the sample into two
groups by PSE: children with at least one parent reporting smoking and
children with no exposure to parental smoking.
2.5. Definition of metabolic syndrome
A modified ATPIII criteria for MetS was employed in this study, in
which MetS was defined by the presence of greater than or equal to
three of the following five components [23]: (1) central obesity defined
as waist circumference ≥ 90th percentile for age and gender (estab-
lished based on the BCAMS study); (2) elevated blood pressure defined
as SBP/DBP ≥ 90th percentile for age, sex and height (according to the
BCAMS study); (3) elevated TG defined as TG ≥ 1.24 mmol/L, equal to
the 90th percentile of the reference population; (4) reduced HDL-C
defined as ≤ 1.03 mmol/L, equivalent to 5th percentile of the reference
population; (5) hyperglycemia defined as FPG ≥ 5.6 mmol/L. Ac-
cording to the Working Group for Obesity in China [29], we used age-
and sex-specific BMI percentiles to define overweight (85th) and obe-
sity (95th) for children and adolescents.
2.6. Statistical analysis
Values were expressed as means (standard deviation), median (in-
terquartile range), percentage (%) or mean ± standard error as ap-
propriate. All skewed distributions were natural log (ln)-transformed
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for the analyses. Two sample t tests were applied to compare con-
tinuous variables. Differences among categorical variables were eval-
uated using chi-square test. Rank sum test was used for ranked data.
Covariance analysis was applied to test the associations of secondhand
smoking status with adiposity-related anthropometric indices, adipo-
kines and cardiometabolic risk factors. Coefficient estimates of log (ln)-
transformed adipokines were converted to the original scale and in-
terpreted as relative differences (in percentages) in comparison to the
reference category [30]. Binary logistic regression models were used to
estimate the odds ratios (OR) for MetS and its components. For all
statistical analyses, a two-tailed p value < 0.05 was considered sta-
tistically significant. Analyses were performed with the Statistical
Package for Social Science (SPSS) 24.0.
3. Results
3.1. Study subjects
The characteristics of subjects stratified by parental smoking status
are summarized in Table 1. There were 2042 (64.8%) children exposed
Table 1
Characteristics stratified by parental smoking status.
Non-exposed (n = 1108) Parental smoking (n = 2042) p
Age (y) 11.7 (3.1) 12.0 (3.1) 0.008
Boys, n (%) 576 (52.0) 1001 (49.0) 0.112
Birthweight (kg) 3.35 (0.53) 3.35 (0.52) 0.758
Tanner stage, n (%) 0.016
Ⅰ 358 (33.4) 623 (31.4)
Ⅱ 159 (14.8) 282 (14.2)
Ⅲ 196 (18.3) 318 (16.0)
Ⅳ 262 (24.4) 499 (25.2)
Ⅴ 98 (9.1) 260 (13.1)
Body weight status, n (%) < 0.001
Normal weight 610 (55.3) 847 (41.7)
Overweigh 184 (16.7) 397 (19.5)
Obesity 310 (28.1) 789 (38.8)
Urban, n (%) 798 (72.0) 1217 (59.6) < 0.001
Lifestyle factors
Daily sleeping hours (h) 8.5 (1.2) 8.5 (1.2) 0.531
Diet scores 36.5 (4.5) 35.4 (4.9) < 0.001
Activity (≥3 times/week), n (%) 619 (56.9) 1126 (56.0) 0.610
Socioeconomic factors
Father's education ≥ university, n (%) 331 (30.3) 340 (16.8) < 0.001
Mother's education ≥ university, n (%) 223 (20.4) 276 (13.6) < 0.001
Unemployment father, n (%) 34 (3.1) 104 (5.2) 0.007
Unemployment mother, n (%) 95 (8.8) 189 (9.5) 0.570
Family history
Any parents has diabetes, n (%) 28 (2.5) 89 (4.4) 0.009
Any parents has hypertension, n (%) 126 (11.4) 240 (11.8) 0.750
Any parents has dyslipidemia, n (%) 90 (8.1) 141 (6.9) 0.211
Father's BMI (kg/m2) 25.13 (3.20) 24.92 (3.26) 0.086
Mother's BMI (kg/m2) 22.92 (3.35) 23.47 (3.47) < 0.001
Adiposity-related anthropometric indices
BMI (kg/m2) 21.01 (4.74) 22.40 (4.97) < 0.001
BMI z-score 0.65 (1.22) 0.94 (1.17) < 0.001
waist circumference (cm) 70.3 (12.5) 73.5 (13.2) < 0.001
FAT% 22.86 (8.31) 25.36 (8.57) < 0.001
Adipokine profiles
Leptin (ng/ml) 4.79 (1.52–11.04) 7.04 (2.39–15.83) < 0.001
Adiponectin (ug/ml) 11.71 (7.92–17.14) 11.05 (7.32–15.58) 0.011
RBP4 (µg/ml) 32.18 (26.05–39.72) 32.87 (27.62–39.97) 0.001
FGF21 (pg/ml) 601.50 (264.00–1538.50) 547.50 (249.00–1353.00) 0.034
Resistin (ng/ml) 14.58 (10.44–21.24) 14.83 (10.70–21.46) 0.841
Osteonectin (µg/ml) 1.05 (0.78–1.44) 1.02 (0.78–1.41) 0.623
Metabolic indices
SBP (mm Hg) 106 (14) 109 (14) < 0.001
DBP (mm Hg) 66 (10) 69 (10) < 0.001
TG (mmol/L) 0.86 (0.63–1.20) 0.91 (0.67–1.24) 0.020
TC (mmol/L) 4.11 (0.81) 4.09 (0.79) 0.545
LDL-C (mmol/L) 2.53 (0.74) 2.56 (0.72) 0.283
HDL-C (mmol/L) 1.43 (0.33) 1.39 (0.32) < 0.001
Fasting glucose (mmol/L) 5.0 (0.5) 5.1 (0.5) 0.002
MetS components
Central obesity, n (%) 301 (27.3) 769 (37.9) < 0.001
Elevated BP, n (%) 280 (25.3) 634 (31.1) < 0.001
Reduced HDL-C, n (%) 97 (8.8) 223 (10.9) 0.055
Elevated TG, n (%) 249 (22.5) 512 (25.1) 0.104
Hyperglycemia, n (%) 111 (10.1) 259 (12.7) 0.028
MetS, n (%) 104 (9.5) 282 (14.0) < 0.001
BMI, body mass index; BMI z-score: standardized by age and gender; FAT%, fat mass percentage; RBP4, retinol binding protein 4; FGF21, fibroblast growth factor 21;
SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cho-
lesterol; TG, triglyceride; BP, blood pressure; MetS, metabolic syndrome. Values displayed as mean (standard deviation), median (interquartile range) or number (%).
Values in bold are significant at p < 0.05.
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to parental smoking. The mean ages of the two groups were 12.0 and
11.7 years, respectively (p < 0.05). The proportions of boys in two
groups were roughly equivalent (p > 0.05). The exposed group was
older, with more overweight and obesity, unhealthier diet, family his-
tory of diabetes and lower socioeconomic status (all p < 0.05). No
relationships of tobacco exposure with sleep and exercise were ob-
served (all p > 0.05).
3.2. Parental smoking, adiposity-related anthropometric indices, and
adipokine profiles
Children with PSE were strongly associated with elevated BMI, BMI
z-score, waist circumference and FAT% (all p < 0.001) (Table 1). In
adjusted analyses, as shown in Table 2, additional adjustments for age,
sex, Tanner stage, residence, diet scores, parents' education, parents'
BMI and family history didn't change the associations between PSE and
adiposity-related anthropometric indices. With respect to adipokines
(Table 2 and Fig. 1), PSE resulted in a 39.2% increase (percent differ-
ence converted to original scale) in leptin, a 11.4% decrease in FGF21, a
4.6% decrease in adiponectin and a 3.9% increase in RBP4 levels, with
adjustment for age, sex, Tanner stage, residence, diet scores, parents'
education, parents' BMI and family history (all p < 0.05). There was
no significant difference in resistin and osteonectin levels between the
two groups (all p > 0.05). However, after further adjustment for BMI
(Fig. 1), only the difference in leptin levels between the two groups
remained significant (percent difference 8.6%, p = 0.017) but was
markedly attenuated.
3.3. Parental smoking and metabolic characteristics
Compared to the non-exposed group, PSE children had increased
SBP, DBP, TG, FPG and decreased HDL-C (all p < 0.05) (Table 1). The
prevalence of MetS was 14% in children exposed to parental smoking
versus 9.5% in those not exposed (p < 0.001). Exposed children had
more frequent central obesity, elevated blood pressure and hypergly-
cemia compared to the non-exposed (all p < 0.05).
In adjusted analyses (Supplementary Table S1), SBP and DBP were
still positively associated with PSE in the model which adjusted for age,
sex, Tanner stage, residence, diet scores, parents' education, parents’
BMI and family history, whilst FPG (p= 0.065) and HDL-C (p= 0.062)
were borderline significant. When further adjusting for BMI, however,
all associations were abolished (all p > 0.05). In sensitivity analysis,
adjustment of waist circumference, or FAT%, or above-mentioned
adipokines instead of BMI did not change the results (data not shown).
In multiple logistic regression (Table 3) when controlling for age,
sex and Tanner stage, PSE was significantly associated with central
obesity (OR 1.63, 95% CI 1.38–1.92, p < 0.001), elevated blood
pressure (OR 1.33, 95% CI 1.13–1.58, p = 0.001), hyperglycemia (OR
1.30, 95% CI 1.02–1.66, p = 0.032) and higher risk of MetS (OR 1.55,
95% CI 1.21–1.98, p < 0.001), but not with altered lipids. After fur-
ther adjustment for residence, lifestyle, socioeconomical factors and
family history, associations of PSE with central obesity (OR 1.59, 95%
CI 1.33–1.90, p < 0.001), elevated blood pressure (OR 1.22, 95% CI
1.02–1.46, p = 0.028) and MetS (OR 1.43, 95% CI 1.11–1.85,
p= 0.006) were still significant (all p < 0.05), whilst attenuated with
additional adjustment for BMI (all p > 0.05). Again, the finding was
unchanged when adjusted for adiposity by including waist cir-
cumference (data not shown) or FAT%, or the above-mentioned adi-
pokine profiles instead of BMI as a covariate.
4. Discussion
Although increasing evidence suggests an association between PSE
and obesity in childhood, studies including adipokine biomarkers to
elucidate such relationship are scarce. Based on this large BCAMS study
of Chinese children, we investigated the association of PSE with a series
of promising adipokines, and we found that PSE was not only associated
with adiposity, but also with unfavorable adipokine profiles including
increased leptin and RBP4 as well as decreased adiponectin and FGF21
levels. These are in part due to the increased adiposity, but the elevated
levels of leptin remained, even when adjusted for BMI. In addition, we
demonstrated the associations of PSE with hypertension and MetS in
Chinese children, which were not confounded by age, sex, puberty,
dietary habits, socioeconomic factors, parents’ BMI and family history.
Notably, these associations no longer held with additional adjustment
for adiposity-related anthropometric indices or adipokines, suggesting
that impaired function of adipose tissue, especially alterations in adi-
pokines levels, might mediate the relation between passive smoking
and cardiometabolic disorders in children.
As expected, our study confirmed previous findings that PSE was
correlated with offspring adiposity, where BMI was adopted as the main
adiposity indicator [2,8,31]. It should be acknowledged that BMI does
not reflect body fat distribution; therefore we also assessed the FAT% (a
supplementary estimate of total adiposity) and waist circumference (a
recommended marker of abdominal adiposity). The consistent findings
when using different anthropometric indices reinforced the conclusion
that PSE was positively associated with offspring adiposity.
Many adipokines are pro-inflammatory but a subset has anti-in-
flammatory functions such as adiponectin. Importantly, the imbalance
of pro- and anti-inflammatory adipokines caused by excess adiposity,
contributes to metabolic dysfunction [13]. In the current study, we
selected six inflammation-related adipokines and found associations
between PSE and adipokine profiles. In addition, controlling for these
adipokines removed the association of PSE and clinical manifestation of
multiple cardiometabolic disorders.
Among the six adipokines we studied, leptin and adiponectin, as
classic pro- and anti-inflammatory adipokines, were the two most stu-
died in literature. Notably, in line with the previous studies [18,32], we
found that childhood tobacco smoke exposure was associated with
elevated leptin and reduced adiponectin. In a study of 990 Swedish
children, participants exposed to secondhand smoke exhibited a 27%
increase in leptin levels (comparable with our 39.2%), while no sig-
nificant difference in adiponectin levels was observed [30]. However,
although observational studies showed discrepancies, available ex-
perimental studies indicated that nicotine could increase leptin levels
[33] and reduce the expression of adiponectin [34]. Therefore, ex-
posure to parental smoking may cause the dysregulation of leptin and
adiponectin, which may subsequently lead to metabolic disorders.
Table 2
Adjusted adiposity parameters and adipokine levels between different parental
smoking status groups.
Non-exposed Parental smoking p
BMI (kg/m2) 21.13 ± 0.13 22.25 ± 0.10 < 0.001
BMI z-score 0.65 ± 0.03 0.93 ± 0.03 < 0.001
Waist circumference (cm) 70.3 ± 0.3 73.1 ± 0.2 < 0.001
FAT% 23.30 ± 0.25 25.18 ± 0.18 < 0.001
Leptin (ng/ml)a 1.41 ± 0.04 1.74 ± 0.03 < 0.001
Adiponectin (µg/ml)a 2.42 ± 0.02 2.38 ± 0.01 0.036
RBP4 (µg/ml)a 3.45 ± 0.01 3.49 ± 0.01 0.006
FGF21 (pg/ml)a 6.51 ± 0.04 6.39 ± 0.03 0.023
Resistin (ng/ml)a 2.72 ± 0.02 2.73 ± 0.01 0.891
Osteonectin (µg/ml)a 0.04 ± 0.02 0.06 ± 0.01 0.596
BMI, body mass index; BMI z-score: standardized by age and gender according;
FAT%, fat mass percentage; RBP4, retinol binding protein 4; FGF21, fibroblast
growth factor 21.
Analysis of covariance controlled for age, sex, Tanner stage, residence, diet
scores, parents' education (highest education level in parents defined by either
parent), parents' BMI and family history (diabetes).
Data are expressed as the mean ± standard error.
Values in bold are significant at p < 0.05.
a Skewed distributions were natural logarithmically transformed.
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Like leptin, RBP4 and resistin generally exhibit pro-inflammatory
properties. RBP4, highly expressed in adipose and liver, enhances the
expression of phosphoenolpyruvate carboxykinase to elevate hepatic
glucose production and attenuates insulin signalling to impair muscle
glucose uptake [13]. It is therefore a known biomarker of insulin re-
sistance and MetS [13,20]. In line with our previous finding that active
smoking increased RBP4 levels in adults [35], the present study showed
that PSE was also associated with increased RBP4 levels in children.
Thus, increased RBP-4 concentrations may serve as a novel link be-
tween smoking and insulin resistance, and MetS. Resistin may activate
suppressor of cytokine signaling 3 (SOCS3) to modulate glucose meta-
bolism and inhibit insulin signalling, promoting inflammation and in-
sulin resistance [13]. A previous study in adults showed that smoking
men had higher resistin levels, and nicotine increased resistin through
Fig. 1. Adjusted levels of adipokines be-
tween different parental smoking status
groups.
Data were natural logarithmically trans-
formed and expressed as mean with stan-
dard error. All p values were adjusted for
age, sex, Tanner stage, residence, diet
scores, parents' education (highest educa-
tion level in parents defined by either
parent), parents' BMI and family history
(diabetes); p’ values were further adjusted
for BMI. (A) The parental smoking group
was associated with increased leptin com-
pared with the non-exposed group. (B) The
parental smoking group had lower adipo-
nectin levels than the non-exposed group,
and the difference was attenuated with
further adjustment for BMI. (C) The par-
ental smoking group was associated with
increased RBP4 levels compared with the
non-exposed group, and the association was
attenuated with further adjustment for BMI.
(D) The difference in FGF21 levels between
the two groups was attenuated after con-
trolling for BMI. (E and F) Resistin and os-
teonectin levels were not significantly dif-
ferent (NS) between the two groups.
RBP4, retinol binding protein 4; FGF21, fi-
broblast growth factor 21.
Table 3
Adjusted associations between parental smoking status and metabolic syndrome and its components.
Model 1 Model 2 Model 2 + BMI Model 2 + FAT% Model 2+adipokine profilesa
OR (95%CI) p OR (95%CI) p OR (95%CI) p OR (95%CI) p OR (95%CI) p
Central obesity 1.63 (1.38–1.92) < 0.001 1.59 (1.33–1.90) < 0.001 – – – – – –
Elevated BP 1.33 (1.13–1.58) 0.001 1.22 (1.02–1.46) 0.028 1.00 (0.83–1.21) 0.988 1.07 (0.89–1.29) 0.472 1.06 (0.87–1.29) 0.550
Reduced HDL-C 1.23 (0.95–1.60) 0.115 1.16 (0.88–1.53) 0.283 0.99 (0.75–1.31) 0.941 1.04 (0.79–1.38) 0.771 1.08 (0.80–1.45) 0.626
Elevated TG 1.31 (0.95–1.35) 0.172 1.09 (0.91–1.32) 0.350 0.93 (0.77–1.13) 0.466 0.99 (0.82–1.20) 0.911 0.85 (0.69–1.05) 0.138
Hyperglycemia 1.30 (1.02–1.66) 0.032 1.17 (0.92–1.51) 0.204 1.14 (0.89–1.47) 0.310 1.15 (0.89–1.48) 0.281 1.16 (0.89–1.52) 0.262
MetS 1.55 (1.21–1.98) < 0.001 1.43 (1.11–1.85) 0.006 1.02 (0.76–1.37) 0.879 1.21 (0.92–1.59) 0.183 1.05 (0.79–1.40) 0.735
HDL-C, high-density lipoprotein cholesterol; BP, blood pressure; TG, triglyceride; MetS, metabolic syndrome.
Model 1: adjusted for age, sex, Tanner stage.
Model 2: adjusted for age, sex, Tanner stage, residence, diet scores, parents' education (highest education level in parents defined by either parent), parents' BMI and
family history (diabetes).
Values in bold are significant at p < 0.05.
a Adipokine profiles include leptin, adiponectin, FGF21 and RBP4. Adipokine levels were natural logarithmically transformed for analyses.
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activation of the KATP channel [36]. However, we did not find a strong
link between PSE and circulating resistin levels among children. Given
the poor knowledge of these associations, our findings underscore the
need for further studies to elucidate the associations.
In contrast to previous work on leptin, adiponectin, resistin and
RBP-4, FGF21 and osteonectin have not yet been reported in previous
research of PSE. FGF21 represses inflammation, promotes fatty acid
oxidation, increases glucose uptake, reduces serum glucagon, improves
insulin sensitivity and protects against MetS [21]. The adipokine os-
teonectin also plays a key role in adipose tissue inflammation and re-
lated metabolic diseases [22]. In the present study, we found that
children exposed to parental smoking had lower FGF21 levels than
controls, but no significant difference in osteonectin levels was ob-
served. More studies are needed to confirm these observations.
In line with previous studies in children [9,31], we demonstrated
the association of passive smoking with MetS in Chinese children. As for
the components of MetS, except for lipids, either central obesity, ele-
vated blood pressure or hyperglycemia showed association with PSE in
the present study. However, previous studies showed discrepancies in
blood pressures [10,31], lipids [7,31] and fasting glucose [31,37].
Different levels of adjusted cofounders, racial difference and small
sample sizes with less power might contribute to these discrepancies.
Besides, it should be noted that sex differences might also account for
the inconsistent results, as we found the adverse effects of tobacco ex-
posure were greater in boys than in girls (Supplementary Table S2).
However, the mechanism involved is unclear and further studies are
warranted to elucidate these sex-related differences.
Interestingly, associations between PSE and cardiometabolic factors
were all attenuated when additional adjustment for adiposity-related
anthropometric indices or adipokine profiles was made, implying that
association between tobacco exposure and cardiometabolic disorders
might be causally linked through excess adiposity and concomitant
adipokine profiles. Moreover, previous adult studies and animal studies
also provided support for our results [15,16,38]. It is noteworthy that
the dysregulated adipokines, as biomarkers for pathophysiological
changes, may initiate cardiovascular disorders in early life. Multiple
behavioral and environmental factors including passive smoking might
impact the cardiometabolic risk through dysregulation of adipokines.
Our study indicated that identifying children with abnormal adipokines
followed by early preventive strategies could be of particular sig-
nificance to lower future cardiovascular risk [21].
China has the largest number of smokers in the world. However,
according to data from the ITC China Project, there has been limited
progress in tobacco control over the last decade [6,39]. Our study adds
evidence on the potential adverse health effects of tobacco, suggesting
that there is an urgent need for implementing strong national smoke-
free laws to reduce the detrimental effects of tobacco exposure, not only
on smokers themselves, but also on passive smokers, especially chil-
dren.
The current study benefits from a large, well-characterized cohort of
individuals, with a wealth of phenotypic information collected ac-
cording to a standardized protocol. We were able to examine a wide
array of cardiometabolic outcomes, controlling for many potential
confounding factors, while the large sample size enabled sufficient
power for statistical inference. Moreover, we systematically analyzed
six inflammation related adipokines, contributing to a better under-
standing of the potential pathways by which tobacco exposure causes
cardiometabolic disorders. Nevertheless, there are several limitations to
the study. First, our self-reported exposure lacked detailed information
to quantify the accumulative exposure that may cause bias and limit
precision of the exposure measurement. Although the metabolites of
nicotine were proposed to quantify the exposure, lack of a unified
standard may lead to incomparable results [38,40]. Second, we did not
distinguish prenatal from postnatal exposure. As individuals generally
start smoking at an early age, it is unlikely that smoking parents
stopped smoking after giving birth to their children. Third, while the
sample size was large, there were not enough subjects to separately
examine maternal smoking as it was rare in this sample. Moreover,
parents' weight and height were recorded through self-report ques-
tionnaires rather than by laboratory examination, and this may have
influenced the accuracy of the data. Lastly, the associations were ex-
amined in cross-sectional settings, which is not sufficient to establish
causality, and future longitudinal studies are necessary to clarify the
current findings.
In conclusion, in this Chinse cohort, we found PSE was not only
associated with fat storage, but also with alteration in plasma adipo-
kines, including increased leptin and RBP4, as well as decreased adi-
ponectin and FGF21, which might explain the association of PSE and
high MetS risk among the children. Our study provides novel insights
into passive smoking and cardiometabolic dysfunction in youth, and
emphasizes the urgency of adopting and implementing complete
smoking bans.
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